Novartis set to buy Avidity Biosciences for more than $10bn

All NewsOctober 26, 2025

Deal would be biggest acquisition under chief executive Vas Narasimhan

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent